Astarabine, a novel leukemia-targeted cytarabine composition allows, for the first time, the delivery of high cytarabine doses for older or unfit patients with acute leukemia. Results of an ongoing phase I/IIa study Meeting Abstract
| Authors: | Zuckerman, T.; Gengrinovitch, S.; Ben-Yakar, R.; Hoffman, R.; Henig, I.; Lavi, N.; Akria, L.; Ofran, Y.; Horowitz, N. A.; Nudelman, O.; Koren-Michowitz, M.; Yeganeh, S.; Tallman, M. S.; Rowe, J. M. |
| Abstract Title: | Astarabine, a novel leukemia-targeted cytarabine composition allows, for the first time, the delivery of high cytarabine doses for older or unfit patients with acute leukemia. Results of an ongoing phase I/IIa study |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394452305073 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.1650.1650 |
| Notes: | Meeting Abstract: 1650 -- Source: Wos |
